PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Celebrating 10 Years of VarioSys: An Unforeseeable Success Story Interview with the Masterminds Behind VarioSys, Dr. Friedrich Haefele and Bernd Wieland

VarioSys entered the market ten years ago and has since revolutionised pharmaceutical production. What was needed was a highly versatile system capable of handling various delivery systems – syringes, cartridges, and vials – while accommodating different filling quantities within a single isolator. This approach contrasted sharply with the traditional method of permanently installing separate filling and closing systems within an isolator for each type of container.

This challenging task was successfully accomplished by the specialised machine manufacturer Bausch+Ströbel in collaboration with isolator manufacturer SKAN, and with the invaluable guidance and support of Dr. Friedrich Haefele, Vice President Biopharma Fill & Finish Boehringer Ingelheim.

The past ten years have proven that this development was the right choice at the time. Over 100 systems have been sold worldwide to date, and demand remains strong, as noted by Bernd Wieland, Director of Regional Sales & Business Development at Bausch+Ströbel. This is mainly thanks to the system’s continuous improvement over time. Like Dr. Friedrich Haefele, Bernd Wieland has been a driving force behind the development from the very start.

As they both remember very well, this success story was not foreseeable at the outset. Dr. Haefele recalls, “It all started for me back in 2009. At that time, I was the department head of the Bio-Pharmaceuticals Division at Boehringer Ingelheim. I had access to a small filling line for liquid and lyophilised vials, but I saw the need to upgrade our lyophiliser line to comply with current technical standards. We had a state-of-the-art system for filling pre-filled syringes, but it couldn’t be adapted for processing vials. Even then, I was looking to add significantly more flexibility to our production process.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026